Cellectis SA
Cellectis SA, a Paris‑based clinical‑stage biotech, focuses on gene‑edited CAR‑T therapies for hematologic and solid cancers, offering a diversified pipeline (ALLO‑501, ALLO‑316, UCART‑22, UCART‑123) and strategic partnerships in the pharmaceutical manufacturing sector.
Headquarters: France (FRA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Manufacturing
- Industry: Pharmaceutical Manufacturing
- Employees: 216
- HQ: Paris
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.